Bempesta EZ Tablet (Bempedoic acid + Ezetimibe)

Sold: 7 Orders Placed
In stock
SKU
SP00097
$0.00

Bempesta EZ Tablet combines two lipid-lowering agents — bempedoic acid and ezetimibe — in a single convenient daily tablet.
It is designed for adults with hypercholesterolemia (high cholesterol) who require additional LDL-C (bad cholesterol) reduction despite lifestyle changes and/or statin therapy.
Bempesta EZ is especially useful for patients who cannot tolerate high-dose statins or need further LDL-C lowering beyond what statins alone provide.

Read More
Bempesta EZ Tablet (Bempedoic Acid 180mg + Ezetimibe 10mg)
PackageQTYPriceAdd To Cart
30 Tablet/s $27.99
60 Tablet/s $55.98
90 Tablet/s $83.97

Introduction of Bempesta EZ Tablet

Bempesta EZ Tablet contains:

  •     Bempedoic acid 180 mg: an ATP citrate lyase inhibitor that lowers LDL-C by reducing cholesterol synthesis in the liver.
  •     Ezetimibe 10 mg: blocks cholesterol absorption in the intestine, further lowering blood cholesterol.

This dual-action fixed-dose combination provides an effective option for high-risk patients who need significant LDL-C reduction or cannot tolerate high-dose statins.

Precautions of Bempesta EZ Tablet:

Before using Bempesta EZ, patients should inform their healthcare provider if they:

  •     Have severe liver disease
  •     Have a history of gout or elevated uric acid levels
  •     Are pregnant, planning pregnancy, or breastfeeding (use is generally not recommended)
  •     Have tendon disorders or a history of tendon rupture

Not recommended for:

  •     Patients with active liver disease
  •     Children and adolescents under 18 years
  •     Use during pregnancy or breastfeeding unless clearly needed

Periodic monitoring of liver enzymes, uric acid, and LDL-C levels is advised during treatment.

Uses of Bempesta EZ Tablet:

Bempesta EZ Tablet helps manage:

  •     Primary hypercholesterolemia (familial or non-familial)
  •     Mixed dyslipidemia
        It is typically used:
  •     In combination with statins when LDL-C targets are not achieved
  •     As monotherapy or with other lipid-lowering therapies in patients intolerant to statins

By combining bempedoic acid (which inhibits cholesterol synthesis in the liver) and ezetimibe (which reduces intestinal cholesterol absorption), Bempesta EZ delivers a complementary, dual mechanism for lowering LDL-C.

Side Effects of Bempesta EZ Tablet:

Most patients tolerate Bempesta EZ well. However, as with any medication, side effects can occur.

Common side effects (usually mild to moderate):

  •     Muscle pain or discomfort
  •     Joint pain
  •     Increased uric acid levels (may rarely trigger gout)
  •     Gastrointestinal symptoms (diarrhea, nausea)

Less common but potentially serious:

  •     Elevated liver enzymes
  •     Tendon rupture (rare; usually in older adults or those on corticosteroids/fluoroquinolones)
  •     Severe allergic reactions (very rare)

Patients should contact a healthcare provider if they experience unexplained muscle pain, significant joint issues, or symptoms of liver problems (e.g., jaundice, dark urine).

FAQs of Bempesta EZ Tablet:

Q1: Can I take Bempesta EZ instead of a statin?
A: Bempesta EZ is usually used with a statin for better LDL-C reduction, but it may be used alone if you cannot tolerate statins.

Q2: How soon will my cholesterol improve?
A: Significant LDL-C reduction can typically be seen within 4–12 weeks of starting treatment.

Q3: What should I do if I miss a dose?
A: Take it as soon as you remember. If it’s almost time for your next dose, skip the missed dose — do not double up.

Q4: Is this medicine safe for long-term use?
A: Clinical studies support its safety for long-term LDL-C lowering, but regular checkups and lab monitoring are recommended.

Q5: Do I still need to follow diet and exercise recommendations?
A: Yes. Bempesta EZ works best as part of a comprehensive cholesterol-lowering plan, including diet and exercise.

Interactions of Bempesta EZ Tablet:

Bempesta EZ may interact with:

  •     High-dose statins (e.g., simvastatin >20 mg or pravastatin >40 mg): may increase risk of muscle-related side effects
  •     Cyclosporine: may raise blood levels of ezetimibe
  •     Fibrates: combination should be used cautiously
  •     Warfarin and other anticoagulants: monitor INR closely, as ezetimibe may affect INR

Always inform your healthcare provider about all medicines, supplements, or herbal products you are taking.

More Information
Manufacturer:Torrent Pharma, India
Trade Name:Nexlizet
Generic Search:Bempedoic acid + Ezetimibe
Strength:180mg/10mg
Write Your Own Review
You're reviewing:Bempesta EZ Tablet (Bempedoic acid + Ezetimibe)
Your Rating